Lloyd Haskell

4.5k citations
69 papers · 2.2k · 2 hit papers · h-index 22

Impact in

Papers in

    • Peripheral Artery Disease Management 25
    • Atrial Fibrillation Management and Outcomes 12
    • Blood Pressure and Hypertension Studies 6
    • Antiplatelet Therapy and Cardiovascular Diseases 5

Lloyd Haskell

61 papers receiving 2.1k citations

Lloyd Haskell's Hit Papers

Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism 2017 · 509 citations
5090+4+8Years since publication100200300400500

Peers

Lloyd Haskell
Comparison fields: 5 of 94
  • Internal Medicine 1.2k
  • Cardiology and Cardiovascular Medicine 958
  • Hematology 198
  • Emergency Medical Services 107
  • Nephrology 88
Replace Theodore E. Spiro with:
Theodore E. Spiro United States
Alfonso Tafur United States
Melissa Forgie Canada
Pierpaolo Di Micco Italy
J Weitz Canada
Chatree Chai‐Adisaksopha Thailand
Nicoletta Riva Italy
J D Stamatakis United Kingdom
Gerald Chi United States
Madelyn Curto United States
Lloyd Haskell relative to Theodore E. Spiro United States Theodore E. Spiro's profile →
Citations per field
00.5×3.7×
Theodore E. Spiro · 1×
Citations per year

Countries citing papers authored by Lloyd Haskell

Since Specialization
Citations

This map shows the geographic impact of Lloyd Haskell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lloyd Haskell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lloyd Haskell more than expected).

Fields of papers citing papers by Lloyd Haskell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lloyd Haskell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lloyd Haskell. The network helps show where Lloyd Haskell may publish in the future.

Co-authors

The 25 scholars most cited alongside Lloyd Haskell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lloyd Haskell Line = papers co-authored together Lloyd Haskell links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 69 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism
Hit paper breakdown →
2017509
2
Rivaroxaban for Thromboprophylaxis in Acutely Ill Medical Patients
Hit paper breakdown →
2013438
3 1998129
4 201191
5 201490
6 201886
7 202074
8 201659
9
Polyarteritis nodosa and familial Mediterranean fever: a report of 2 cases and review of the literature.
198956
10 200950
11 201445
12 201442
13 201437
14 199936
15 201535
16 198835
17 198929
18 202128
19 201822
20 202022

About Lloyd Haskell

Lloyd Haskell is a scholar working on Surgery, Cardiology and Cardiovascular Medicine, Internal Medicine, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 69 papers that have together received 2.2k indexed citations. Recurring topics across this work include Peripheral Artery Disease Management (25 papers), Venous Thromboembolism Diagnosis and Management (17 papers), Atrial Fibrillation Management and Outcomes (12 papers), Blood Pressure and Hypertension Studies (6 papers), Antiplatelet Therapy and Cardiovascular Diseases (5 papers), Vascular Procedures and Complications (3 papers), Cerebrovascular and Carotid Artery Diseases (3 papers) and Blood Coagulation and Thrombosis Mechanisms (3 papers). The work is most often cited by research in Internal Medicine (1.2k citations), Cardiology and Cardiovascular Medicine (958 citations), Hematology (198 citations), Emergency Medical Services (107 citations) and Nephrology (88 citations). Lloyd Haskell has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include Theodore E. Spiro, Alex C. Spyropoulos, Geno J. Merli, Alexandre Mebazaa, Dayi Hu, Victor F. Tapson, Harry R. Büller, Sebastian Schellong, Russell D. Hull and Rupert Bauersachs. Their work appears in journals such as Journal of the American College of Cardiology, Circulation, The Journal of Clinical Pharmacology, Journal of the American Heart Association and Journal of Thrombosis and Haemostasis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact